TY - JOUR
T1 - 5-Thioxoimidazolidine-2-one derivatives
T2 - Synthesis, anti-inflammatory activity, analgesic activity, COX inhibition assay and molecular modelling study
AU - El-Sharief, Marwa A.M.Sh
AU - Abbas, Samir Y.
AU - El-Sharief, Ahmed M.Sh
AU - Sabry, Nermien M.
AU - Moussa, Ziad
AU - El-Messery, Shahenda M.
AU - Elsheakh, Ahmed R.
AU - Hassan, Ghada S.
AU - El Sayed, Mardia T.
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/6
Y1 - 2019/6
N2 - A series of 5-imino-4-thioxo-2-imidazolidinone derivatives with different substituents at N 1 and N 3 was synthesized with high yield and excellent purity by the reaction of different N-arylcyanothioformamide derivatives with isocyanate derivatives. Treatment 5-imino-4-thioxo-2-imidazolidinone derivatives with acidic medium afforded 4-thioxoimidazolidin-2,5-dione derivatives. The structures of the obtained products were established based on spectroscopic IR, 1 H NMR, 13 C NMR, 1 H, 1 H-COSY, HSQC and elemental analyses. The anti-inflammatory activity of the synthesized compounds through the carrageenan-paw edema model as well as in vitro COX-1 and COX-2 inhibition assay were evaluated where most of the synthesized compounds showed significant anti-inflammatory activity. Mostly, all of our synthesized compounds have greater activity more than celecoxib toward both cyclooxygenase enzymes. All of the tested compounds (except one compound) exhibited IC 50 valves for COX-2 ranged from 0.001 × 10 −3 to 0.827 × 10 −3 µM while the reference drug has IC 50 40.0 × 10 −3 µM. Furthermore, the analgesic activity of such compounds was also determined. Molecular modeling study was also conducted to rationalize the potential as anti-inflammatory agents of our synthesized compounds by predicting their binding modes, binding affinities and optimal orientation at the active site of the COX enzymes.
AB - A series of 5-imino-4-thioxo-2-imidazolidinone derivatives with different substituents at N 1 and N 3 was synthesized with high yield and excellent purity by the reaction of different N-arylcyanothioformamide derivatives with isocyanate derivatives. Treatment 5-imino-4-thioxo-2-imidazolidinone derivatives with acidic medium afforded 4-thioxoimidazolidin-2,5-dione derivatives. The structures of the obtained products were established based on spectroscopic IR, 1 H NMR, 13 C NMR, 1 H, 1 H-COSY, HSQC and elemental analyses. The anti-inflammatory activity of the synthesized compounds through the carrageenan-paw edema model as well as in vitro COX-1 and COX-2 inhibition assay were evaluated where most of the synthesized compounds showed significant anti-inflammatory activity. Mostly, all of our synthesized compounds have greater activity more than celecoxib toward both cyclooxygenase enzymes. All of the tested compounds (except one compound) exhibited IC 50 valves for COX-2 ranged from 0.001 × 10 −3 to 0.827 × 10 −3 µM while the reference drug has IC 50 40.0 × 10 −3 µM. Furthermore, the analgesic activity of such compounds was also determined. Molecular modeling study was also conducted to rationalize the potential as anti-inflammatory agents of our synthesized compounds by predicting their binding modes, binding affinities and optimal orientation at the active site of the COX enzymes.
KW - Analgesic activity
KW - Anti-inflammatory activity
KW - COX inhibition assay
KW - Imidazolidin-2,5-diones
KW - Imidazolidineiminothiones
KW - N-Arylcyanothioformamides
UR - http://www.scopus.com/inward/record.url?scp=85063678256&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063678256&partnerID=8YFLogxK
U2 - 10.1016/j.bioorg.2019.03.075
DO - 10.1016/j.bioorg.2019.03.075
M3 - Article
C2 - 30953887
AN - SCOPUS:85063678256
SN - 0045-2068
VL - 87
SP - 679
EP - 687
JO - Bioorganic Chemistry
JF - Bioorganic Chemistry
ER -